Hiroyoshi Doihara

PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer

Takeo Fujita, Hiroyoshi Doihara, Kaoru Kawasaki et al. · British Journal of Cancer · 2006 · 156 citations · Full text

Medicine, Oncology, Pharmacology +17

Aberrant Promoter Methylation in Human DAB2 Interactive Protein (<b> <i>hDAB2IP</i> </b>) Gene in Breast Cancer

Hideaki Dote, Shinichi Toyooka, Kazunori Tsukuda et al. · Clinical Cancer Research · 2004 · 110 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers

Mitsuya Itoh, Takayuki Iwamoto, Junji Matsuoka et al. · Breast Cancer Research and Treatment · 2013 · 105 citations · Full text

Medicine, Molecular Biology, Oncology +15

The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells

Hirokuni Ikeda, Naruto Taira, Fumikata Hara et al. · Breast Cancer Research · 2010 · 89 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Evaluation of Breast Lymphatic Pathways with Indocyanine Green Fluorescence Imaging in Patients with Breast Cancer

Yutaka Ogasawara, Hirokuni Ikeda, Mina Takahashi et al. · World Journal of Surgery · 2008 · 87 citations

Medicine, Oncology, Radiology +15